Explore our latest innovations and publications and discover how we leverage human iPSC technology to catalyze drug discovery.
Uncovering ALS pathology and potential drug targets with in vitro iPSC models
The status of drug discovery and development for Alzheimer's disease
Research highlights: Target identification to modulate neuroinflammation in Alzheimer’s disease
Case Study: Modeling Friedreich’s ataxia using patient-derived iPSCs
Adoption of complex disease modeling brings new optimism and hope to drug discovery
White paper: Advancing drug discovery for neurodegenerative diseases